openPR Logo
Press release

Metabotropic Glutamate Receptor Market is Set to Experience a Revolutionary Growth

05-12-2025 01:12 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Metabotropic Glutamate Receptor

Metabotropic Glutamate Receptor

The global metabotropic glutamate receptor (mGluR) market is valued at approximately $2.5 billion in 2024, driven by increased research into neurological disorders and the expanding pipeline of mGluR-targeted therapies. The market is projected to grow significantly, forecasting a value of around $4.6 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 6.5% during the period from 2025 to 2034.

Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Metabotropic Glutamate Receptor market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Metabotropic Glutamate Receptor market.

This report is also available in the following languages : Japanese (代謝型グルタミン酸受容体), Korean (대사성 글루타메이트 수용체), Chinese (代谢型谷氨酸受体), French (Récepteur métabotropique du glutamate), German (Metabotroper Glutamatrezeptor), and Italian (Recettore metabotropico del glutammato), etc.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59618

Key Companies:
Pfizer Inc., Eli Lilly and Company, Novartis AG, Johnson & Johnson, AstraZeneca PLC, Sanofi S.A., Biogen Inc., Merck & Co., Inc., Amgen Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, GSK (GlaxoSmithKline PLC), Bayer AG, Otsuka Pharmaceutical Co., Ltd., Neuren Pharmaceuticals Limited

Market Segmentation
By Product Type
mGluR1
mGluR2
mGluR3
mGluR4
mGluR5

By Application
Neurology
Psychiatry
Pain Management
Other Applications

By End User
Pharmaceutical Companies
Research Institutions
Hospitals
Others

By Technology
Gene Therapy
Small Molecule Drugs
Antibody-Based Therapy

By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Explore Full Report here: https://exactitudeconsultancy.com/reports/59618/global-metabotropic-glutamate-receptor-market

If opting for the Global version of Metabotropic Glutamate Receptor Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=59618

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Metabotropic Glutamate Receptor market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Metabotropic Glutamate Receptor market.

Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/59618

Reasons To Buy The Metabotropic Glutamate Receptor Market Report:

➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.

Other Reports:

https://www.nepalbusinesschannel.com/article/725742001-automotive-plastic-additives-market-is-projected-to-reach-usd-12-30-billion-by-2029-exactitude-consultancy

https://www.openpr.com/news/4008168/personal-use-defibrillator-market-growth-demand-price

https://pr.chillicothevoice.com/article/3D-Semiconductor-Packaging-Market-Outlook-Report-2024-or-Report-which-provides-an-in-depth-analysis-Based-on-Regions-Applications-Exactitude-Consultancy?storyId=6699175a709b0518e4154d75

https://www.tuvalubusinessday.com/article/730626086-airport-information-systems-market-is-projected-to-grow-to-usd-5-23-billion-by-2032-exactitude-consultancy

http://www.todayinbanking.com/article/731294842-rf-probe-card-market-is-expected-to-be-valued-at-usd-4-360-97-million-by-2033-exactitude-consultancy

https://www.industrytimesfalklandislands.com/article/731888178-photolithography-market-is-expected-to-be-valued-at-usd-12-99-billion-by-2030-exactitude-consultancy

https://smb.alexcityoutlook.com/article/Microencapsulated-Pesticides-Market-is-expected-to-be-valued-at-USD-67176-billion-by-2033-or-Exactitude-Consultancy?storyId=66b4bb28ff399ea85e270f21

http://www.telecomstoday.com/article/736775084-air-fryer-market-is-expected-to-be-valued-at-usd-2-84-billion-by-2033-exactitude-consultancy

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabotropic Glutamate Receptor Market is Set to Experience a Revolutionary Growth here

News-ID: 4010784 • Views:

More Releases from Exactitude Consultancy

Chemotherapy Induced Nausea and Vomiting Market Massive Growth opportunity Ahead
Chemotherapy Induced Nausea and Vomiting Market Massive Growth opportunity Ahead
Introduction Chemotherapy remains a cornerstone of cancer treatment, but it comes with a heavy burden of side effects. Among these, nausea and vomiting are among the most distressing, significantly impacting patient quality of life and adherence to therapy. Chemotherapy-induced nausea and vomiting (CINV) can lead to treatment discontinuation, malnutrition, and hospitalization if poorly managed, making effective supportive care a critical part of oncology practice. Over the past decade, advances in serotonin (5-HT3)
Cervix Lesion Market Outlook 2025-2034: Screening, Early Detection, and Advanced Therapies Driving Progress
Cervix Lesion Market Outlook 2025-2034: Screening, Early Detection, and Advanced …
In 2024, the global cervix lesion market is valued at USD 2.9 billion and is projected to reach USD 6.1 billion by 2034, growing at a CAGR of 7.8% (2025-2034). The steady rise reflects the combined effect of heightened awareness, government-led prevention programs, and innovative diagnostic and therapeutic approaches. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71190 Market Overview: Key Highlights Market Size (2024): USD 2.9 Billion Forecasted Market Size (2034): USD
c-MET Mutated Non-Small Cell Lung Cancer (NSCLC) Market Outlook 2025-2034: Precision Oncology Driving Growth
c-MET Mutated Non-Small Cell Lung Cancer (NSCLC) Market Outlook 2025-2034: Preci …
In 2024, the global c-MET mutated NSCLC market is valued at USD 1.2 billion and is projected to reach USD 3.5 billion by 2034, growing at a CAGR of 11.4% (2025-2034). This strong trajectory reflects rising adoption of molecular testing, broader access to MET inhibitors, and robust clinical trial activity across regions. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71188 Market Overview: Key Highlights Market Size (2024): USD 1.2 Billion Forecasted Market
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted Therapies Driving Growth
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted The …
In 2024, the global carcinoid tumor market is estimated at USD 2.4 billion and is projected to reach USD 5.1 billion by 2034, growing at a CAGR of 7.6% (2025-2034). Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71186 Market Overview: Key Highlights Market Size (2024): USD 2.4 Billion Forecasted Market Size (2034): USD 5.1 Billion CAGR (2025-2034): 7.6% Largest Region (2024): North America (~45% share) Fastest-Growing Region: Asia-Pacific (>9% CAGR) Top Therapies: Somatostatin analogs (octreotide, lanreotide),

All 5 Releases


More Releases for Metabotropic

Metabotropic Glutamate Receptor 7 Market Worldwide Industry Analysis, Future Dem …
The Metabotropic Glutamate Receptor 7 Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The metabotropic glutamate receptor 7 (mGlu7) is a G protein-coupled receptor that plays important roles in synaptic transmission and plasticity in the brain. mGlu7 is expressed presynaptically on excitatory and inhibitory neurons, and its activation inhibits the release of glutamate and GABA, respectively. Previous work has shown
Global Metabotropic Glutamate Antagonists Market Analysis By Major Manufacturers …
Globally, Metabotropic Glutamate Antagonists key manufacturers include Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH and Cerecor Inc., etc. Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus are top 3 players and held % sales share in total in 2022. Global Metabotropic Glutamate Antagonists Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the
Global Metabotropic Glutamate Receptor Market Size, Share and Trends: Ken Resear …
The global Metabotropic Glutamate Receptor market was valued at .98 Million USD in 2020 and will grow with a CAGR of 12.17% from 2020 to 2027, based on HNY Research newly published report. For More Details:- https://www.kenresearch.com/healthcare/medical-devices/metabotropic-glutamate-receptor/470362-91.html The prime objective of this report” Global and Regional Metabotropic Glutamate Receptor Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027” is to provide the insights on the post COVID-19 impact which will help
Metabotropic Glutamate Receptor Market 2021 Size, Growth Analysis Report, Foreca …
The Metabotropic Glutamate Receptor Market was valued at 2 million USD in 2021 and will reach 5 million USD by the end of 2028, growing at a CAGR of +11% during 2021-2028. A Latest intelligence report published by Market Research Inc titled as Global Metabotropic Glutamate Receptor Market Size, Share, Growth, Industry Trends and Forecast To 2028 is a comprehensive study accumulated to offer Latest insights about acute features of the
Know Reasons Why Metabotropic Glutamate Receptor Market May See Potentially High …
Advance Market Analytics released a new market study on Global Metabotropic Glutamate Receptor Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study
Metabotropic Glutamate Receptor (MRG) Market to boost its value by year 2023
Metabotropic glutamate receptors or mGluRs (MGRs) are a form of glutamate receptors that are active through an indirect metabotropic process. They are members of the group C family of G-protein-coupled receptors or GPCRs. MGRs provide a novel target to develop therapeutic agents that are anticipated to have a dramatic impact on the treatment of a wide variety of psychiatric and neurologic disorders. The growth in the incidence of neurological disorders is